Nwam LLC Vertex Pharmaceuticals Inc Transaction History

Nwam LLC

$1.6 Billion
Q3 2024

A detailed history of Nwam LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nwam LLC holds 5,000 shares of VRTX stock, worth $2.04 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

5,000

Previous 4,992 0.16%

Holding current value

$2.04 Million

Previous $2.34 Million 0.6%

% of portfolio

0.14%

Previous 0.69%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $3,680 - $4,046	8 Added 0.16%	5,000 $2.33 Million
Q2 2024 Jul 23, 2024	BUY	$392.81 - $485.53 $51,850 - $64,089	132 Added 2.72%	4,992 $2.34 Million
Q1 2024 May 09, 2024	SELL	$407.69 - $446.08 $815 - $892	-2 Reduced 0.04%	4,860 $2.03 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $3,773 - $4,517	11 Added 0.23%	4,862 $1.98 Million
Q3 2023 Oct 31, 2023	SELL	$338.18 - $362.46 $3,381 - $3,624	-10 Reduced 0.21%	4,851 $1.69 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $3,773 - $4,222	-12 Reduced 0.25%	4,861 $1.71 Million
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $21,242 - $24,232	-75 Reduced 1.52%	4,873 $1.54 Million
Q4 2022 Feb 07, 2023	BUY	$285.76 - $321.48 $8,572 - $9,644	30 Added 0.61%	4,948 $1.43 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $29,025 - $32,386	106 Added 2.2%	4,918 $1.42 Million
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $225,796 - $281,140	-961 Reduced 16.65%	4,812 $1.39 Million
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $221 - $260	-1 Reduced 0.02%	5,773 $1.51 Million
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $591,036 - $746,099	3,339 Added 137.13%	5,774 $1.27 Million
Q3 2021 Nov 03, 2021	BUY	$181.39 - $202.99 $441,684 - $494,280	2,435 New	2,435 $442,000
Q3 2020 Oct 16, 2020	SELL	$255.65 - $303.1 $298,854 - $354,323	-1,169 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$225.48 - $295.8 $1,352 - $1,774	6 Added 0.52%	1,169 $339,000
Q1 2020 Apr 16, 2020	SELL	$199.77 - $247.81 $19,977 - $24,781	-100 Reduced 7.92%	1,163 $277,000
Q4 2019 Jan 23, 2020	BUY	$166.71 - $223.91 $210,554 - $282,798	1,263 New	1,263 $277,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.

Account